NorthWest Biotherapeutics Inc (NWBO): German Health Exemption program has been...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	19
Posts	848
Boards Moderated	0
Alias Born	12/04/2013

TheFollower

Re: None

Thursday, 07/30/2015 5:48:55 PM

Thursday, July 30, 2015 5:48:55 PM

German Health Exemption program has been under way:

http://www.nwbio.com/dcvax-l-hospital-exemption-program-now-under-way-in-germany/

BETHESDA, MD, October 14, 2014 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the DCVax-L Hospital Exemption Program that was approved by the German regulatory authority earlier this year is now under way. The first patient with Glioblastoma multiforme (GBM) brain cancer has begun the treatment process, additional patients are being assessed and a waiting list has been established.

Things we don't know & wish we did:
Is the money accruing for this & will it all be paid when negotiations are complete?
Are they complete?
Are there many patients in the program?
How's the patient(s) doing?